Corpus Intelligence IC Memo — ADVENTHEALTH MURRAY 2026-04-26 21:27 UTC
IC Memo — ADVENTHEALTH MURRAY
Investment Committee Memorandum | GA | 29 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTHEALTH MURRAY

CCN 110050 | MURRAY, GA | 29 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVENTHEALTH MURRAY is a 29-bed suburban community hospital in MURRAY, GA with $39.3M in net patient revenue and a 0.8% operating margin. The hospital serves a payer mix of 35.8% Medicare, 7.0% Medicaid, and 57.3% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.8% to 8.1% (+736bps).

Net Revenue HCRIS$39.3M
Current EBITDA COMPUTED$297K
Operating Margin COMPUTED0.8%
Occupancy HCRIS26.4%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS17.8%
Distress Probability ML52.8%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
75
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 0.8% places it above the state median. Among 75 size-comparable peers (14-58 beds), the median margin is -3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-58), prioritizing same-state peers. 75 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH MURRAY (Target)GA29$39.3M0.8%
TANNER MEDICAL CENTER-VILLA RIGA58$289.8M33.3%
KENNESTONE HOSPITAL AT WINDY HGA55$160.5M0.7%
PIEDMONT MOUNTAINSIDE HOSPITALGA52$131.2M10.5%
UNION GENERAL HOSPITALGA39$108.6M2.4%
TATTNALL HOSPITAL COMPANY LLCGA25$101.7M41.9%
PHOEBE SUMTER MEDICAL CENTER GA54$101.0M-1.6%
MEADOWS REGIONAL MEDICAL CENTEGA57$91.8M-18.8%
MILLER COUNTY HOSPITALGA25$81.6M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$825K+210bp18mo
Cost to Collect4.5%2.5%$786K+200bp12mo
Denial Rate Reduction12.0%6.5%$778K+198bp12mo
A/R Days Reduction5200.0%3800.0%$478K+122bp9mo
Clean Claim Rate88.0%96.0%$25K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$825K
Cost to Collect
$786K
Denial Rate Reduction
$778K
A/R Days Reduction
$478K
Clean Claim Rate
$25K
Total EBITDA Uplift$2.9M
Current EBITDA$297K
+ RCM Uplift+$2.9M
Pro Forma EBITDA$3.2M
Current Margin0.8%
Pro Forma Margin8.1%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$456K$30.9M67.64x132.3%
Base (11x exit)10.0x11.0x$456K$34.1M74.73x137.0%
Bull Case9.0x11.0x$411K$43.8M106.63x154.4%
Bull (12x exit)9.0x12.0x$411K$47.9M116.62x159.0%
Bear Case11.0x10.0x$502K$16.3M32.40x100.5%
Bear (11x exit)11.0x11.0x$502K$18.1M35.97x104.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 26.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 52.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 75 hospitals with 14-58 beds
  • Same-state prioritization (n=76)
  • Comp margins: P25=-20.1% / P50=-3.8% / P75=5.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.